Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLT 2022

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Mar 04, 2021 8:33pm

237 Views

Post# 32724708

RE:RE:RE:RE:RE:TLT 2022

99942Apophis wrote: If this is proved successful in trial it will be in the news whoever buys won't be able to hide it maybe slow it down a touch. Investigations will be hard and heavy if a large pharmaceutical tries to bury it. This is worth a lot of coin to the buyer.

"Slow it down a touch" Yep, I agree. IF Merck is the winner they will want this product out. But unlike competitors they will have a bunch of Keytruda 'stuff' they will have to walk away from.

<< Previous

Bullboard Posts

Next >>

How a truck transportation and logistics company leverages acquisitions and technology